Researchers have been excited about this new drug, a novel dual treatment showing significant outcomes in early trials for weight loss . It acts by targeting both hormones : GLP-1 and GIP, which , when https://kobifudq727917.arwebo.com/63280855/this-new-possibility-for-weight-loss